Preview

Problems of Endocrinology

Advanced search

Diabeton MR in the treatment of type 2 diabetes

https://doi.org/10.14341/probl20085433-7

Abstract

Type 2 diabetes mellitus (T2DM) is recognized as a non-infectious epidemic of our time. According to the WHO, in 2007 there were about 246 million patients with diabetes in the world, experts predict that by 2025 there will be about 380 million, of which more than 90% will be patients with type 2 diabetes [23]. The age of patients at the time of the onset of T2DM is gradually decreasing, there is an alarming increase in the risk of developing this disease in young people, adolescents and children [1]. The study of the pathophysiological basis for the development of T2DM made it possible to present the future extent of its prevalence and their causes.

About the Author

V. N. Shishkova

State Research Center for Preventive Medicine of Roszdrav


Russian Federation


References

1. Дедов И. И., Ремизов О. В., Петеркова В. А. // Сахарный диабет. - 2001. - № 4. - С. 26-31.

2. Дедов И. П., Чазова Т. Е., Сунцов Ю. И. Эпидемиология сахарного диабета. - М., 2003.

3. Дедов И. И., Шестакова М. В. Сахарный диабет. - М., 2003.

4. Дедов И. И., Шестакова М. В. Сахарный диабет и артериальная гипертензия. - М., 2006.

5. Мамедов М. II. Метаболический синдром - больше, чем сочетание факторов риска: принципы диагностики и лечения: Пособие для врачей. - М., 2006

6. American Diabetes Association. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes //Diabetes Care. - 19S9. - Vol. 12. - P. 573-579.

7. Bak J., Schmitz O., Niels S. et al. // Diabetes. - 1989. - Vol. 38-P. 1343-1350.

8. Bruttomesso D., Pianta A., Verio A. et al. // Diabetes. - 1999. -Vol. 48. - P. 99-105.

9. Countinho M., Gentein Н. C. et al. // Diabetes Care. - 1999. -Vol. 22. - P. 233-240.

10. The DECODE Study Group. Glucose tolerance and cardiovascular mortality, comparison of fasting and 2-hour diagnostic criteria // Arch. Intern. Med. - 2001. - Vol. 161. - P. 397-404.

11. Droln P. and the Diamicron MR Study Group // J. Diabet. Complications. - 2000. - Vol. 14. - P. 185-191.

12. Fava D., Cassone-Faldetta M., Laurenti O. et al. // Diabet. Med. - 2002. - Vol. 19. - P. 752-757

13. Francilford М., Frey N.. Paralre М. et al. // J. Nutr. Hlth Aging. - 2001. - Vol. 5, spec. N. - P. 14.

14. Fu Z, Yan Т.. Chen Y. J. et al. // Metabolism. - 1992. -Vol. 41.-P. 33-35.

15. Gram J., Jespersen J., Kold A. // Metabolism. - 1988. - Vol. 37. - P. 937-943.

16. Grcgorio F., Ambrosi F., Cristallini S. et al. // Diabet. Res. Clin. Prac. - 1992. - Vol. 18. - P. 197-206.

17. Johnson A., Argyrakl M., Thow Jr. et al. // Diabet. Med. - 1991.-Vol. 8. -P. 243-253.

18. Kaneto H., Fujii J., Myint T. et al. // Biochem. J. - 1996. - Vol. 320 - P. 885-863.

19. Kimoto K., Suzuki K., Kizaki T. et al. // Biochem. Biophys. Res. Commun. - 2003. - Vol. 303. - P. 112-119.

20. Leschke M., Schwenk B. et al. // Clin. Res. Cardiol. - 2006. -Vol.95. N 1.-P. 93-102.

21. O'Brien R. C, Luo M., Balaz N. et al. //J. Diabet. Complications. - 2000. - Vol. 14. - P. 201-206.

22. Riccio A., Lisato G., Vigili de Kreutzenberg S. et al. // Metabolism. - 1996. - Vol. 45. - P. 1196-1202.

23. Sarah Wild, Goika Roglic et al. // Diabetes Care. - 2004. - Vol. 27.-P. 1047-1053.

24. Schemthaner G., Di Vario U., Grimaldi A. // Diabetologia. - 2003. - Vol. 46. - Suppl. 2. - P. A28.

25. Serrl O., Roussin A., Buithieu J. et al. Submitted to the EASD 2004.

26. Steven E., Kahn С. // J. Clin. Endocrinol. Metab. - 2001. - Vol. 86. N 9. - P. 4047-4058.

27. The UKPDS Group. UK prospective diabetes study 16: overview of six year therapy of type 2 diabetes - a progressive disease // Diabetes. - 1995. - Vol. 44. - P. 1249-1258.

28. Wallace T. M., Matthews D. R. // Textbook of Diabetes / Eds J. С Pickup, G. Williams. - 3-nd Ed. - Oxford, 2005. -P. 45-18.

29. Wascher Tc, Boes V. // Diabetologia. - 2002. - Vol. 45. - Suppl. 2. - P. A 275.

30. Zurro H. I, Lavielle R. // Сurr. Med. Res. Opin. - 1986.- Vol. 10. - P. 351-358.


Review

For citations:


Shishkova V.N. Diabeton MR in the treatment of type 2 diabetes. Problems of Endocrinology. 2008;54(3):3-7. (In Russ.) https://doi.org/10.14341/probl20085433-7

Views: 18566


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)